Olatunji B. Alese

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer

Richard D. Kim, Vincent Chung, Olatunji B. Alese et al. · JAMA Oncology · 2020 · 449 citations · Full text

Medicine, Oncology, Pharmacology +16

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy

Mehmet Asım Bilen, Dylan J. Martini, Yuan Liu et al. · Cancer · 2018 · 161 citations · Full text

Medicine, Immunology, Oncology +16

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Mehmet Asım Bilen, Julie M. Shabto, Dylan J. Martini et al. · BMC Cancer · 2019 · 125 citations · Full text

Medicine, Immunology, Oncology +17

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Arta M. Monjazeb, Anita Giobbie‐Hurder, Ana Lako et al. · Clinical Cancer Research · 2021 · 101 citations · Full text

Medicine, Oncology, Radiation Oncology +17